Thalidomide (50 μg/mL) potentiates the anti-tumor activity of icotinib against the proliferation of both PC9 and A549 cells, and this effect is correlated with apoptosis and cell migration.
Thalidomide (50μg / mL) waxay awood u siineysaa waxqabadka anti-buro ee icotinib kahortaga faafitaanka labada unug ee PC9 iyo A549, saameyntana waxay kuxirantahay apoptosis iyo unuga guuritaanka.